205 related articles for article (PubMed ID: 15541000)
21. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
22. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
[TBL] [Abstract][Full Text] [Related]
23. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
24. Altered CSF orexin and α-synuclein levels in dementia patients.
Wennström M; Londos E; Minthon L; Nielsen HM
J Alzheimers Dis; 2012; 29(1):125-32. PubMed ID: 22207004
[TBL] [Abstract][Full Text] [Related]
25. How to diagnose dementia with Lewy bodies: state of the art.
Geser F; Wenning GK; Poewe W; McKeith I
Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
[TBL] [Abstract][Full Text] [Related]
26. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Dalfó E; Ferrer I
Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
[TBL] [Abstract][Full Text] [Related]
27. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.
Duda JE; Giasson BI; Mabon ME; Lee VM; Trojanowski JQ
Ann Neurol; 2002 Aug; 52(2):205-10. PubMed ID: 12210791
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
[TBL] [Abstract][Full Text] [Related]
29. Rostral raphe involvement in Lewy body dementia and multiple system atrophy.
Benarroch EE; Schmeichel AM; Sandroni P; Parisi JE; Low PA
Acta Neuropathol; 2007 Sep; 114(3):213-20. PubMed ID: 17639427
[TBL] [Abstract][Full Text] [Related]
30. Tuft-shaped astrocytes in Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
[TBL] [Abstract][Full Text] [Related]
31. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
[TBL] [Abstract][Full Text] [Related]
32. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
[TBL] [Abstract][Full Text] [Related]
33. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
34. Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
Saldaña M; Mullol J; Aguilar E; Bonastre M; Marin C
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):308-16. PubMed ID: 17442064
[TBL] [Abstract][Full Text] [Related]
35. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
Bosco DA; Fowler DM; Zhang Q; Nieva J; Powers ET; Wentworth P; Lerner RA; Kelly JW
Nat Chem Biol; 2006 May; 2(5):249-53. PubMed ID: 16565714
[TBL] [Abstract][Full Text] [Related]
38. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
Rockenstein E; Schwach G; Ingolic E; Adame A; Crews L; Mante M; Pfragner R; Schreiner E; Windisch M; Masliah E
J Neurosci Res; 2005 Apr; 80(2):247-59. PubMed ID: 15765523
[TBL] [Abstract][Full Text] [Related]
39. Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies.
Power JH; Shannon JM; Blumbergs PC; Gai WP
Am J Pathol; 2002 Sep; 161(3):885-94. PubMed ID: 12213717
[TBL] [Abstract][Full Text] [Related]
40. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.
Ishikawa A; Piao YS; Miyashita A; Kuwano R; Onodera O; Ohtake H; Suzuki M; Nishizawa M; Takahashi H
Ann Neurol; 2005 Mar; 57(3):429-34. PubMed ID: 15732120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]